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AbstrACt 
Objective To investigate trends in the incidence of testing 
for vitamin D deficiency and the prevalence of patients 
with circulating concentrations of 25-hydroxyvitamin D 
(25(OH)D) indicative of deficiency (<30 nmol/L) between 
2005 and 2015.
Design Longitudinal analysis of electronic health 
records in The Health Improvement Network primary care 
database.
setting UK primary care.
Intervention None.
Participants The analysis included 6 416 709 participants 
aged 18 years and older.
Primary outcomes Incidence of having a blood test 
for vitamin D deficiency between 2005 and 2015, the 
prevalence with blood 25(OH)D <30 nmol/L and the effects 
of age, ethnicity and socioeconomic status on these 
measures were assessed.
results After a mean follow-up time of 5.4 (SD 3.7) years, 
there were 210 502 patients tested for vitamin D deficiency. 
The incidence of vitamin D testing rose from 0.29 per 1000 
person-years at risk (PYAR) (95% CI 0.27 to 0.31) in 2005 
to 16.1 per 1000 PYAR (95% CI 15.9 to 16.2) in 2015. Being 
female, older, non-white ethnicity and more economically 
deprived were all strongly associated with being tested. One-
third (n=69 515) had 25(OH)D <30 nmol/L, but the per cent 
deficient among ethnic minority groups ranged from 43% 
among mixed ethnicity to 66% in Asians. Being male, younger 
and more economically deprived were also all associated with 
vitamin D deficiency (p<0.001).
Conclusions Testing for vitamin D deficiency increased over 
the past decade among adults in the UK. One-third of UK 
adults who had a vitamin D test performed in primary care 
were vitamin D deficient, and deficiency was much higher 
among ethnic minority patients. Future research should 
focus on strategies to ensure population intake of vitamin 
D, particularly in at-risk groups, meets recommendations to 
reduce the risk of deficiency and need for testing.
There has been widespread interest in the 
research community of the health effects of 
vitamin D on the musculoskeletal system and 
on conditions such as respiratory illness,1 
cardiovascular disease, certain cancers and 
some neurological conditions.2 The resulting 
research and media attention generated from 
this interest has led to increased awareness 
among medical professionals and the general 
public of the potential role that vitamin D 
may have in maintaining good health.3 
While the prevalence of low circu-
lating concentrations of vitamin D (circu-
lating 25-hydroxyvitamin D (25(OH)D) 
<25 nmol/L) among adults in the UK is 
around 20% (National Diet and Nutrition 
Survey (NDNS)),4 the incidence of profound 
vitamin D deficiency in adults (osteomalacia) 
is rare.5 6 In the UK, national guidance for 
vitamin D deficiency is focused on popula-
tion recommendations to supplement with 
vitamin D to prevent deficiency rather than 
testing and treating patients for vitamin D defi-
ciency. Specifically, the Department of Health 
advises that all adults should consider taking a 
daily vitamin D supplement containing 100% 
of the recommended nutrient intake (RNI) 
of vitamin D of 10 µg during the autumn and 
winter months, and adults at risk of devel-
oping vitamin D deficiency, such as people 
who are frail or housebound, in a care home 
strengths and limitations of this study
 ► This study includes a very large sample size with 
data up to the end of 2015.
 ► The clinical data in this study was collected 
prospectively.
 ► A large proportion of patients had missing data for 
ethnicity, which is an important determinant of being 
tested for vitamin D deficiency and being vitamin D 
deficient.
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or who cover up most of their skin when outdoors, should 
take a daily vitamin D supplement throughout the year.7 
Further to this, recent clinical guidance issued by the 
National Osteoporosis Society (NOS)8 and the National 
Institute for Clinical Excellence9 states that patients 
should not be routinely tested for vitamin D deficiency.
Despite clinical guidance to restrict testing for vitamin 
D deficiency, there have been reports showing increasing 
rates of testing over the past decade in some parts of the 
UK.10 11 This has been accompanied by an increase in 
the number of prescriptions for vitamin D supplements 
(colecalciferol) and ensuing cost to the National Health 
Service (NHS).12 It is not clear whether this increasing 
trend has continued after clinical guidance was published 
or whether these finding are true for the wider UK popu-
lation and at-risk populations such as certain ethnic 
minority groups. The Health Improvement Network 
(THIN) database includes general practice (GP) records 
of over 11 million patients from over 600 UK GPs and 
offers the opportunity to examine incidence rates of 
patients tested for vitamin D deficiency over time. The 
objective of this analysis is to calculate the incidence rates 
of testing for vitamin D deficiency and the proportion 
of patients with circulating concentrations of 25(OH)D 
indicative of deficiency (ie, <30 nmol/L) and to examine 
whether this varies by year, socioeconomic status, sex, age 
or ethnicity of the patient.
MethODs
This study was an open cohort design using THIN primary 
care database that contains health records for >11 million 
patients from over 600 GPs in the UK. The distribution 
of age, sex, prevalence of major medical conditions and 
mortality rates in the THIN cohort is generalisable to 
the UK population.13 The diagnoses in the THIN data-
base are recorded using a hierarchical system called Read 
Codes, which are terms or short-phrases used to describe 
a health-related concept in GP records.14 Collection of 
data for THIN was approved by the South-East Multi-
centre Research Ethics Committee in 2003; under the 
terms of this approval, studies must undergo indepen-
dent scientific review.
study population and period
All data included in this study were from practices that 
met the acceptable mortality reporting and acceptable 
computer usage standards—measures of quality assur-
ance for THIN data.15 16 Patients aged 18 years and older 
who were registered with a THIN practice contributing 
data between 1 January 2005 and 31 December 2015 were 
included in this analysis.
Read Codes for vitamin D tests were used as the 
outcome in this analysis; this included values for total 
vitamin D, 25-hydroxyvitamin D3 and 25-hydroxyvitamin 
D2. As many patients also had circulating concentrations 
of vitamin D tested on multiple occasions, only the first 
test was used in the analysis. Some patients had their first 
recorded test for vitamin D before the date of entry to 
THIN (1 January 2005) or before they turned 18 years 
and these patients were excluded from the analysis 
(online supplementary figure 1). Of the 210 502 patients 
tested for vitamin D deficiency, 67 607 (32.1%) had at 
least one repeat test. Of these patients, 38% were retested 
<6 months from their first test and 63% were retested <12 
months from their first test. On average, 67 607 patients 
had circulating 25(OH)D retested 3.7 times.
Patient and public involvement
Patients or the public were not involved in setting the 
research question or the outcome measures, nor were 
they involved in developing plans for design or implemen-
tation of the study. Patients or the public were not asked 
to advise on interpretation or writing up of results. There 
are no plans to disseminate the results of the research to 
study participants, the relevant patient community or the 
public.
statistical analysis
Age at entry was categorised into the following age 
groups: 18–24, 25–34, 35–44, 45–54, 55–64 and ≥65 years. 
Ethnicity was categorised into five groups based on those 
used in the UK Census: white, black or black British, 
mixed, Asian or Asian British and other (which includes 
Chinese, Middle Eastern and Pacific). Socioeconomic 
group was based on the Townsend deprivation score 
and divided into fifths with the lowest corresponding to 
the least deprived and the highest to the most deprived. 
Patients with missing data on ethnicity and Townsend 
deprivation score were assigned to a separate category 
for that variable and included in the regression analysis. 
The overall crude incidence of having a vitamin D test 
was estimated per 1000 person-years at risk (PYAR). This 
was calculated by totalling the number of patients with a 
first recording for a blood test for vitamin D deficiency 
between 2005 and 2015, and then dividing this by the 
number of person-years of follow-up of the patients for 
this period. Crude incidence rates by calendar year were 
calculated by restricting the person years of follow-up 
to each year in question. Person-years of follow-up were 
calculated from the date of entry to the THIN database 
which was the latest of the date of practice registration 
(plus 1 year), the date the practice met two predefined 
quality indicators for electronic data recording (accept-
able mortality recoding and acceptable computer usage) 
or 1 January 2005 up to whichever came first: having a 
blood test for vitamin D deficiency, exit from the THIN 
database (transferred practice or died), the last date prac-
tice data were collected or 31 December 2015.
Poisson regression models were used to estimate inci-
dence rate ratios (IRRs) and 95% CIs of having a blood 
test for vitamin D deficiency by age group, ethnicity and 
socioeconomic group for men and women separately. 
The analyses were also repeated with restriction to those 
patients with at least 12 months of follow-up before the 
first vitamin D test.
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Logistic regression models were used to estimate the 
risk of vitamin D deficiency (25(OH)D <30 nmol/L)8 
among participants who had a test for vitamin D defi-
ciency according to age at blood test, ethnicity, socioeco-
nomic group, year and month of blood test for men and 
women separately. This was undertaken after setting the 
value of 25(OH)D to 4 nmol/L for patients with 25(OH)
D <5 nmol/L, and setting the values of 25(OHD) to 
201 nmol/L for patients with 25(OH)D >200 nmol/L. 
To assess the influence of month of blood collection on 
blood concentrations of 25(OH)D, a simple mathematical 
model of log-transformed blood vitamin D concentration 
by month of blood collection (as a categorical variable) 
was fitted. Standardised concentrations of 25(OH)D were 
calculated by adding the residuals from this model to the 
overall mean log blood vitamin D value and exponenti-
ating these values, and the resulting 25(OH)D concentra-
tions ‘standardised for month of blood collection’ were 
used for these analyses.
All statistical analyses were performed using Stata statis-
tical software, V.15 (StataCorp, College Station, Texas, 
USA). Two-sided p values <0.05 were considered to be 
statistically significant.
This study cohort had 6 416 709 patients from 689 GP 
practices of whom 210 502 had at least one blood test to 
measure 25(OH)D concentrations from 2005 to 2015 
with a mean follow-up time of 5.4 (SD 3.7) years. The 
mean age of the men was 43 years and the mean age of 
the women was 44 years (table 1). Ethnicity was missing 
for more than half of the patients but among those 
with information on ethnicity, the majority were white 
(88.1%), followed by Asian or Asian British (4.7%), other 
(3.2%), black or black British (3.1%) and mixed (0.9%).
Analysis of the time trends in the incidence of patients 
being tested for vitamin D deficiency show a strong 
upward trend from 2005 to 2015 (figure 1). The crude 
incidence rate increased from 0.29 (95% CI 0.27 to 0.31) 
per 1000 person-years in 2005 to 16.08 (95% CI 15.92 to 
16.23) per 1000 PYAR in 2015 (figure 1 and online supple-
mentary table 1). The time trends in testing for vitamin D 
deficiency were much higher in women (2005: 0.46 (95% 
CI 0.43 to 0.50) and 2015: 22.94 (95% CI 22.68 to 23.21 
per 1000 person-years) than in men (2005: 0.11 (95% CI 
0.10 to 0.13) and 2015: 9.30 (95% CI 9.13 to 9.47 per 1000 
person-years, online supplementary table 2).
The incidence rates and adjusted incidence rate ratios 
for vitamin D testing according to several demographic 
variables for men and women separately are shown in 
table 2. The incidence rate of vitamin D deficiency testing 
for men was 3.44 per 1000 PYAR (95% CI 3.41 to 3.46) 
Table 1 Descriptive characteristics of patients 18 years and older in the THIN database
Characteristic All Men Women
Age at entry, years, mean (SD) 43.3 (19.0) 42.6 (18.1) 44.0 (19.7)
Age categories (years), n (%)*
  18–24 1 269 812 (19.8%) 619 579 (19.7%) 650 233 (19.9%)
  25–34 1 316 390 (20.5%) 638 713 (20.3%) 677 677 (20.7%)
  35–44 1 180 086 (18.4%) 612 932 (19.5%) 567 154 (17.3%)
  45–54 901 352 (14.1%) 465 198 (14.8%) 436 154 (13.3%)
  55–64 755 174 (11.8%) 378 467 (12.1%) 376 707 (11.5%)
  ≥65 993 895 (15.5%) 426 246 (13.6%) 567 649 (17.3%)
Ethnicity, n (%)
  White 2 497 397 (38.9%) 1 168 524 (37.2%) 1 328 873 (40.6%)
  Asian or Asian British 89 180 (1.4%) 41 597 (1.3%) 47 583 (1.5%)
  Black or black British 24 388 (0.4%) 11 078 (0.4%) 13 310 (0.4%)
  Mixed 132 602 (2.1%) 70 570 (2.3%) 62 032 (1.9%)
  Other 91 863 (1.4%) 41 202 (1.3%) 50 661 (1.6%)
  Not known 3 581 279 (55.8%) 1 808 164 (57.6%) 1 773 115 (54.1%)
Socioeconomic group, fifths, n (%)
  1 (least deprived) 1 400 936 (21.8%) 688 591 (21.9%) 712 345 (21.8%)
  2 1 264 659 (19.7%) 617 290 (19.7%) 647 369 (19.8%)
  3 1 304 497 (20.3%) 636 675 (20.3%) 667 822 (20.4%)
  4 1 200 411 (18.7%) 584 967 (18.6%) 615 444 (18.8%)
  5 (most deprived) 854 733 (13.3%) 425 265 (13.5%) 429 468 (13.1%)
  Not known 391 473 (6.1%) 188 347 (6.0%) 203 126 (6.2%)
*The per cent for some variables may not add to 100 due to rounding.
THIN, The Health Improvement Network.
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and for women it was 8.77 per 1000 PYAR (95% CI 8.73 
to 8.82). Asian women had the highest incidence rate of 
testing for vitamin D deficiency at 59.70 per 1000 PYAR 
(95% CI 58.75 to 60.67). Men aged 18–25 years had the 
lowest incidence rate of testing for vitamin D deficiency 
at 1.82 per 1000 PYAR (95% CI 1.77 to 1.87). Older 
men were almost four times more likely to be tested for 
vitamin D deficiency compared with younger men. Older 
women were almost twice as likely to be tested for vitamin 
D deficiency compared with younger women. Compared 
with patients with white ethnicity, those who were Asian 
were over six times more likely to be tested for vitamin D 
deficiency (IRR=6.60, 95% CI 6.42 to 6.79 for men and 
IRR=6.56, 95% CI 6.44 to 6.68 for women). Patients whose 
ethnicity was black, mixed or other were two to three times 
more likely to be tested compared with those with white 
ethnicity. Those whose ethnicity was not known were less 
likely to be tested for vitamin D deficiency compared 
with patients whose ethnicity was white. Compared with 
patients who were the least deprived, the most deprived 
were about one and a half times more likely to be tested 
for vitamin D deficiency. Patients whose deprivation was 
not known were more than twice as likely to be tested for 
vitamin D deficiency compared with patients who were 
the least deprived. The unadjusted IRR for men and 
women are shown in online supplementary table 3.
Table 3 shows the prevalence and OR of having blood 
concentrations of 25(OH)D indicative of deficiency (after 
Figure 1 Crude incidence rate of testing of blood vitamin 
D levels in primary care in adults 18 years and older, 2005–
2015. The solid line represents the incidence rate each year 
with the corresponding 95% CIs (dashed lines).
Table 2 Incidence of testing for vitamin D deficiency by sociodemographic factors for men and women*
Incidence rate of vitamin D testing per 1000 PYAR 
(95% CI) Adjusted IRR (95% CI)†
Men Women Men Women
Overall 3.44 (3.41 to 3.46) 8.77 (8.73 to 8.82) 1 (ref) 2.51 (2.49 to 2.53)
Age (years)
  18–24 1.82 (1.77 to 1.87) 6.29 (6.19 to 6.39) 1 (ref) 1 (ref)
  25–34 2.44 (2.39 to 2.50) 8.52 (8.42 to 8.63) 1.18 (1.14 to 1.23) 1.26 (1.23 to 1.28)
  35–44 3.03 (2.98 to 3.09) 9.19 (9.09 to 9.30) 1.70 (1.64 to 1.76) 1.56 (1.53 to 1.59)
  45–54 3.88 (3.81 to 3.95) 9.57 (9.46 to 9.69) 2.34 (2.26 to 2.42) 1.74 (1.70 to 1.77)
  55–64 4.23 (4.15 to 4.31) 9.12 (9.00 to 9.23) 2.73 (2.64 to 2.82) 1.73 (1.69 to 1.77)
  ≥65 5.73 (5.64 to 5.83) 9.46 (9.35 to 9.56) 3.70 (3.58 to 3.83) 1.84 (1.80 to 1.88)
Ethnicity
  White 3.90 (3.85 to 3.94) 9.30 (9.23 to 9.37) 1 (ref) 1 (ref)
  Asian or Asian British 22.53 (21.99 to 23.08) 59.70 (58.75 to 60.67) 6.60 (6.42 to 6.79) 6.56 (6.44 to 6.68)
  Black or black British 14.13 (13.58 to 14.71) 33.71 (32.89 to 34.55) 3.74 (3.59 to 3.91) 3.41 (3.33 to 3.50)
  Mixed 7.93 (7.11 to 8.84) 22.49 (21.16 to 23.89) 2.49 (2.23 to 2.79) 2.54 (2.39 to 2.70)
  Other 12.88 (12.31 to 13.49) 28.56 (27.75 to 29.40) 3.60 (3.43 to 3.78) 3.02 (2.93 to 3.11)
  Not known 2.27 (2.24 to 2.30) 6.19 (6.14 to 6.24) 0.62 (0.61 to 0.63) 0.68 (0.67 to 0.69)
Socioeconomic group, fifths
  1 (least deprived) 2.64 (2.59 to 2.69) 7.00 (6.92 to 7.08) 1 (ref) 1 (ref)
  2 2.73 (2.68 to 2.79) 6.99 (6.91 to 7.08) 1.01 (0.99 to 1.04) 0.98 (0.96 to 1.00)
  3 3.47 (3.41 to 3.53) 8.79 (8.69 to 8.89) 1.26 (1.23 to 1.29) 1.18 (1.16 to 1.20)
  4 3.77 (3.70 to 3.84) 9.83 (9.72 to 9.95) 1.32 (1.29 to 1.36) 1.26 (1.24 to 1.28)
  5 (most deprived) 4.51 (4.42 to 4.60) 11.34 (11.19 to 11.48) 1.49 (1.45 to 1.54) 1.38 (1.36 to 1.41)
  Not known 7.23 (7.03 to 7.44) 16.97 (16.66 to 17.29) 2.32 (2.24 to 2.40) 2.02 (1.97 to 2.06)
*Results are presented separately for men and women because of a statistically significant interaction between sex and age group (p<0.0001).
†Adjusted for age group, ethnicity and socioeconomic group where appropriate.
IRR, incidence rate ratio; PYAR, person-years at risk.
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standardising for month of blood collection) by age, 
ethnicity and socioeconomic status for men and women 
in analyses restricted to those patients who were tested 
for vitamin D deficiency. One-third of patients had circu-
lating concentrations of 25(OH)D <30 nmol/L. Women 
were 7% less likely to be vitamin D deficient compared 
with men (OR=0.93 95% CI 0.91 to 0.95, p<0.001). There 
was a lower risk of being deficient with older age; men 
and women 65 years and older had a 30% and 18% 
lower risk of being vitamin D deficient compared with 
patients aged 18–25 years, respectively. Compared with 
white patients, patients who were black, mixed or other 
ethnicity had over two times the risk of having blood 
vitamin D concentrations indicative of deficiency, and 
Asian patients had more than five to almost six times 
the risk of being vitamin D deficient. Patients who were 
the most deprived had more than twice the risk of being 
vitamin D deficient compared with those who were the 
least deprived (OR=2.24, 95% CI 2.10 to 2.38 for men and 
OR=2.23, 95% CI 2.14 to 2.32 for women).
Results in figure 2 show the proportion of patients with 
circulating concentrations of 25(OH)D <30 nmol/L by 
month and year of blood collection. There was a strong 
effect of month of blood collection on vitamin D defi-
ciency with the highest per cent being tested in January to 
March and the lowest per cent tested in July to September 
each year. After standardising 25(OH)D concentrations 
Table 3 Associations between sociodemographic characteristics and having circulating 25-hydroxyvitamin D <30 nmol/L for 
men and women*†
Prevalence (95% CI)% Adjusted OR (95% CI)‡
Men Women Men Women
Overall 34.4 (34.0 to 34.8)% 32.5 (32.3 to 32.7)% 1.0 (ref) 0.93 (0.91 to 0.95)
Age (years)
  18–24 43.5 (41.6 to 45.4)% 41.0 (39.9 to 42.1)% 1.0 (ref) 1.0 (ref)
  25–34 42.5 (41.2 to 43.8)% 38.4 (37.7 to 39.1)% 0.83 (0.76 to 0.92) 0.78 (0.74 to 0.83)
  35–44 39.5 (38.4 to 40.5)% 35.5 (34.9 to 36.0)% 0.74 (0.67 to 0.81) 0.78 (0.74 to 0.82)
  45–54 35.2 (34.3 to 36.1)% 31.3 (30.7 to 31.8)% 0.72 (0.66 to 0.79) 0.72 (0.68 to 0.76)
  55–64 31.4 (30.5 to 32.3)% 27.7 (27.2 to 28.3)% 0.66 (0.60 to 0.72) 0.64 (0.61 to 0.68)
  ≥65 30.1 (29.5 to 30.8)% 30.2 (29.8 to 30.6)% 0.70 (0.64 to 0.76) 0.82 (0.78 to 0.86)
Ethnicity
  White 25.6 (25.1 to 26.2)% 24.1 (23.7 to 24.4)% 1.0 (ref) 1.0 (ref)
  Asian or Asian British 65.5 (64.4 to 66.7)% 66.7 (65.9 to 67.5)% 5.04 (4.75 to 5.35) 5.93 (5.70 to 6.17)
  Black or black British 52.7 (50.7 to 54.7)% 50.1 (48.9 to 51.3)% 2.64 (2.42 to 2.88) 2.59 (2.46 to 2.73)
  Mixed 46.9 (41.5 to 52.4)% 42.3 (39.3 to 45.3)% 2.23 (1.78 to 2.79) 2.07 (1.83 to 2.35)
  Other 51.3 (49.0 to 53.6)% 47.5 (46.0 to 48.9)% 2.67 (2.42 to 2.95) 2.54 (2.39 to 2.71)
  Not known 31.5 (30.9 to 32.1)% 30.1 (29.7 to 30.4)% 1.39 (1.34 to 1.45) 1.41 (1.38 to 1.45)
Socioeconomic group, fifths
  1 (least deprived) 24.3 (23.5 to 25.1)% 23.2 (22.7 to 23.6)% 1.0 (ref) 1.0 (ref)
  2 27.7 (26.9 to 28.6)% 26.0 (25.5 to 26.6)% 1.18 (1.10 to 1.25) 1.14 (1.10 to 1.19)
  3 33.3 (32.4 to 34.1)% 31.3 (30.8 to 31.8)% 1.37 (1.29 to 1.46) 1.37 (1.32 to 1.42)
  4 38.5 (37.6 to 39.4)% 36.6 (36.1 to 37.2)% 1.63 (1.54 to 1.74) 1.65 (1.59 to 1.71)
  5 (most deprived) 46.7 (45.7 to 47.7)% 44.7 (44.0 to 45.3)% 2.24 (2.10 to 2.38) 2.23 (2.14 to 2.32)
  Not known 40.3 (38.9 to 41.7)% 38.8 (37.9 to 39.7)% 1.69 (1.57 to 1.82) 1.72 (1.64 to 1.81)
*Results are presented separately for men and women because of a statistically significant interaction between sex and age group (p<0.0001).
†Corrected for month of blood collection.
‡Adjusted for age group, ethnicity and socioeconomic group where appropriate.
Figure 2 Per cent of patients with circulating concentrations 
of 25-hydroxyvitamin D (25(OH)D) <30 nmol/L by month and 
year of blood collection, 2005–2015. Per cent each quarter of 
the year with the corresponding 95% CIs (dashed lines).
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for month of blood collection, and adjusting for sex, age, 
ethnicity and socioeconomic status, there was a statis-
tically significant association between the year of blood 
collection and the per cent of patients with vitamin D 
deficiency; over time, patients tested for vitamin D defi-
ciency had a slightly lower risk of being vitamin D defi-
cient (OR per year=0.913, 95% CI 0.909 to 0.917).
In sensitivity analysis, it made little material difference 
to the risk of being tested for vitamin D deficiency after 
censoring the first year of follow-up (online supplemen-
tary table 4). Results in online supplementary table 5 
show the distribution of patients according to categories 
of circulating concentrations of 25(OH)D after standard-
ising blood concentrations of vitamin D for month of 
blood collection; 33% had 25(OHD) <30 nmol/L, 30% 
had concentrations between 30 and 50 nmol/L, 23% had 
concentrations between 50 and 75 nmol/L and 14% had 
concentrations of 25(OH)D ≥75 nmol/L. The geometric 
mean circulating concentrations of 25(OH)D for men 
and women by age group, ethnicity and socioeconomic 
status are shown in online supplementary table 6. The 
geometric mean concentration of 25(OH)D was highest 
among white men (41.9, 95% CI 41.6 to 42.2 nmol/L) 
and white women (44.0, 95% CI 43.8 to 44.2 nmol/L). 
Asian men and women had the lowest mean concentra-
tions of 25(OH)D (23.9, 95% CI 23.6 to 24.3 nmol/L and 
23.3, 95% CI 23.1 to 23.5 nmol/L, respectively).
DIsCussIOn
There was more than a 50-fold increase in the incidence 
of testing for vitamin D deficiency in UK primary care 
between 2005 and 2015. Patients belonging to ethnic 
minority groups and those who were more economically 
deprived had a greater risk of being tested for vitamin D 
deficiency and were more likely to have blood concentra-
tions of 25(OH)D indicative of deficiency. On the other 
hand, patients older than 65 years were almost twice 
as likely to be tested for vitamin D deficiency but were 
less likely to have vitamin D deficiency compared with 
younger patients. Over one-third of patients tested for 
vitamin D deficiency had sufficient blood concentrations 
of 25(OH)D and this was more common among patients 
who were older, white and the least deprived.
This is the first study in the UK to calculate the inci-
dence of testing for vitamin D deficiency among adults 
over time. Others have shown a dramatic increase in the 
rates of testing for vitamin D among children in primary 
care from 2008 to 2014 and have also shown that children 
with Asian, black, mixed and other ethnicity were more 
likely to be tested compared with white children.17 Zhao 
et al11 showed that the number of requests for vitamin D 
tests among adult patients in primary care practices in 
Liverpool increased substantially from 2007 to 2012 as 
others have demonstrated in other parts of the UK,10 but 
neither of these reports in adults included incidence rates 
for vitamin D testing by ethnicity or socioeconomic status.
Results from the 2012/2013 to 2013/2014 NDNS showed 
that 22% of men and 15% of women aged 19–64 years had 
blood concentrations of 25(OH)D <25 nmol/L.4 This anal-
ysis showed slightly higher rates of vitamin D deficiency 
of 34% among men and 33% among women. This is not 
surprising given there was a higher proportion of patients 
tested for vitamin D deficiency who were more likely to 
have lower blood concentrations of vitamin D than the 
general population (such as patients from ethnic minority 
groups)18 19 and choice of a higher cut point to define 
vitamin D deficiency (<30 nmol/L) in this analysis. There is 
a lack of global consensus regarding the choice of cut points 
used to define vitamin D deficiency meaning that it can often 
be difficult to quantify the extent of vitamin D deficiency and 
compare rates across studies.8 20–22 The most recent results 
from the NDNS also showed a lower prevalence of vitamin 
D deficiency among adults over 65 years compared with 
younger adults.4 The finding of higher rates of testing for 
vitamin D deficiency but lower rates of deficiency in older 
women could be because these women were more likely to 
be diagnosed with osteoporosis and have vitamin D defi-
ciency corrected before beginning treatment.8 23 If they 
were taking vitamin D supplements before being tested for 
vitamin D deficiency then this would explain the lower rates 
of vitamin D deficiency. Although it should be noted that 
NOS does not recommend routine testing for vitamin D 
deficiency in patients who are co-prescribed treatment for 
osteoporosis and a vitamin D supplement.8
There was no indication that the incidence rates of testing 
for vitamin D deficiency showed any sign of decreasing after 
clinical guidance was published in 2013 recommending 
patients should not be routinely tested for vitamin D defi-
ciency in primary care, although the incidence curve 
suggested a slight inflection point in 2013. While the 
absolute number of patients with blood concentrations of 
25(OH)D <30 nmol/L increased over time, peaking in 2013 
at over 13 000, there was a slight decrease in the per cent 
of patients with vitamin D deficiency from 2005 to 2015. If 
more test laboratories replaced automated immunoassays 
with the gold standard tandem mass spectrometry (which 
reads higher values) over time, this may have reduced the 
proportion of patients with vitamin D deficiency.24 Neverthe-
less, an analysis of primary care records in Liverpool where 
25(OH)D was measured using tandem mass spectrometry 
also showed a reduction in the proportion of patients diag-
nosed with vitamin D deficiency from 2007 to 2012.11 There-
fore, an alternative explanation for the small decrease in the 
proportion of patients with vitamin D deficiency over time 
could be due to the large increase in the number of patients 
undergoing testing for vitamin D deficiency, suggesting that 
testing for vitamin D deficiency is being performed less selec-
tively over time.
Other countries such as Australia,25 Canada26 and France27 
have also shown a substantial increase in the number of 
tests for vitamin D deficiency in recent times. In response 
to the large number of tests for vitamin D deficiency and 
rising cost to the healthcare service in Alberta, Canada, 
the laboratory services division developed an additional 
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tool in the laboratory ordering system, whereby clinicians 
had to identify the medical indication(s) for testing blood 
25(OH)D concentrations. Nine months after this crite-
ria-based approach to ordering tests for vitamin D levels 
was introduced, the number of vitamin D tests fell by 92% 
(from around 250 000 to 20 000), greatly reducing the 
number of unnecessary tests for 25(OH)D while not missing 
testing blood 25(OH)D in patients with clinically relevant 
indications.26
The implementation of population-based approaches 
to ensure adequate intake of vitamin D is another strategy 
that may contribute to a reduction in the need to test for 
vitamin D deficiency. This approach has been adopted in 
Finland where the fortification of liquid dairy products and 
fat spreads with higher amounts of vitamin D in combina-
tion with vitamin D supplementation has greatly reduced the 
number of adults with low concentrations of 25(OH)D.28 In 
the UK, an RNI for vitamin D of 10 µg/day has been set to 
ensure that 97.5% of the population achieves blood concen-
trations of 25(OH)D >25 nmol/L all year round.22 However, 
the majority of the population are not meeting this recom-
mendation with the mean intake of vitamin D from foods 
in adults 19 years and older in the most recent NDNS was 
only 28%–33% of the RNI.4 Public Health England recom-
mends that all adults should consider taking a vitamin D 
supplement, but only a small proportion of adults follow this 
guidance; 30% of adults reported taking a supplement that 
might contain vitamin D during the past year (ie, cod liver 
oil and other fish oils, calcium only or with vitamin D, multi-
vitamins (no minerals) or multivitamins and minerals).29 
Public health strategies that encourage more widespread 
fortification of staple foods with vitamin D30 31 in combina-
tion with provision of vitamin D supplements (particularly 
to at-risk groups) will ensure the majority of the population 
meet this RNI which in turn will lower the prevalence of 
vitamin D deficiency in the population and reduce the need 
for patients to be tested for vitamin D deficiency in primary 
care.
Strengths of this study include a very large sample size 
with data up to the end of 2015 and use of a database 
with clinical data that is collected prospectively. Limita-
tions include a large proportion of patients who had 
missing data for ethnicity, which is an important deter-
minant of being tested for vitamin D deficiency and 
being vitamin D deficient. Individuals with missing data 
on ethnicity were included in a separate category and 
these individuals had lower rates of testing for vitamin D 
deficiency but higher rates of deficiency compared with 
those whose ethnicity was white. Therefore, it is possible 
that the true influence of ethnicity on vitamin D testing 
and deficiency was overestimated or underestimated.
In summary, results from this analysis show a 50-fold 
increase in testing for vitamin D deficiency among 
adults in UK primary care from 2005 to 2015. Although 
these results showed that patients at risk of vitamin D 
deficiency are more likely to be tested and be vitamin 
D deficient, public health strategies that prevent these 
at-risk groups from developing vitamin D deficiency 
may be a more cost-effective way to reduce the burden 
of vitamin D deficiency.32 Future research should focus 
on strategies to reduce the need to test for vitamin 
D deficiency in primary care while ensuring that the 
intake of vitamin D meets the recommended levels to 
reduce the risk of deficiency in the population.
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